LeMaitre Vascular (LMAT) Reports Q2 Loss of $0.06, Misses by a Penny
LeMaitre Vascular, Inc. (Nasdaq: LMAT) reports a Q2 loss of $0.06, 1 cent lower than the analyst estimate of ($0.05). Revenues for the quarter were $12.7 million, versus the consensus of $11.91 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
